Paid Clinical Trials in Washington

Washington has 1,820 paid clinical trials enrolling now across cities including Seattle, Spokane and Tacoma. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Washington include Fred Hutchinson Cancer Center, UW Medicine and Seattle Children's, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,820 clinical trials

↓ Download CSV

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for Locally Advanced Pancreatic Adenocarcinoma

274 locations incl. Anchorage

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06998940·Phase 3·Recruiting

Apply to this trial

Weight Loss in Adults Using Semaglutide (Real-world Study)

for Overweight

Drug: Semaglutide

1 location in Seattle

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07627074·Recruiting

Apply to this trial

A Study of TAK-505 in Adults With Solid Tumors

for Malignant Solid Tumors

15 locations incl. Orange

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07436728·Phase 1, Phase 2·Recruiting

Apply to this trial

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for Cardiovascular Disease and Lipoprotein(a)

Drug: Pelacarsen

115 locations incl. Andalusia

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07517263·Phase 3·Recruiting

Apply to this trial

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for Obesity

Drug: NNC0487-0111

202 locations incl. Alexander City

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07567001·Phase 3·Not Yet Recruiting

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for Obesity or Overweight

39 locations incl. Pelham

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07575399·Phase 3·Recruiting

Apply to this trial

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

for Major Depressive Disorder

27 locations incl. Gilbert

Sponsor: Definium Therapeutics US, Inc.

Sex: All·Age: 18 - 74

Code: NCT07592689·Phase 3·Recruiting

Apply to this trial

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Drug: Rituximab

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06738368·Phase 2·Recruiting

Apply to this trial

Dasatinib for HIV-1 Reservoir Reduction

for HIV Infections

3 locations incl. Chicago

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18+

Code: NCT07342491·Phase 1·Recruiting

Apply to this trial

Mobile App-Based Intervention to Improve Toothbrushing in Children and Teens With Autism

for Autism Spectrum Disorder

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 8 - 17

Code: NCT07446413·Enrolling By Invitation

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for Solid Tumors

Drug: Adagrasib

17 locations incl. Phoenix

Sponsor: Mirati Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07415031·Phase 2·Recruiting

Apply to this trial

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

for Type 2 Diabetes

6 locations incl. Lincoln

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07606066·Recruiting

Apply to this trial

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for Obesity

Drug: NNC0487-0111

17 locations incl. San Diego

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07571005·Phase 3·Recruiting

Apply to this trial

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for Obesity

Drug: NNC0487-0111

20 locations incl. Gilbert

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07571109·Phase 3·Recruiting

Apply to this trial

Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact

for Suicide Prevention

3 locations incl. Centralia

Sponsor: University of Washington

Sex: All·Age: 10+

Code: NCT06499740·Recruiting

Apply to this trial

Disulfiram for Treatment of Retinal Degeneration

for Inherited Retinal Dystrophy Primarily Involving Sensory Retina

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT05626920·Phase 1, Phase 2·Recruiting

Apply to this trial

Collaboration for Down Syndrome Progress (CDP)

for Down Syndrome

16 locations incl. Orange

Sponsor: RTI International

Sex: All·Age: All ages

Code: NCT07625579·Recruiting

Apply to this trial

Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System

for Tricuspid Valve Disease

35 locations incl. Birmingham

Sponsor: P+F Products + Features USA Inc.

Sex: All·Age: 18 - 85

Code: NCT06458907·Not Yet Recruiting

CPNF Intervention Development and Testing

for Alcohol Use

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18 - 24

Code: NCT07036198·Not Yet Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for Advanced Biliary Tract Cancer

23 locations incl. Duarte

Sponsor: J-Pharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT07265674·Phase 3·Recruiting

Apply to this trial

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

for Urinary Tract Infection

3 locations incl. Houston

Sponsor: Baylor College of Medicine

Sex: Male·Age: 0 Months - 5 Months

Code: NCT07508124·Phase 4·Recruiting

Apply to this trial

A Vaccine Communication Training Intervention for Pediatric Inpatient Clinicians

for Preventive Health Services (PREV HEALTH SERV)

1 location in Seattle

Sponsor: Seattle Children's Hospital

Sex: All·Age: All ages

Code: NCT07552857·Not Yet Recruiting

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

for Depressive Disorder, Major

Drug: Seltorexant

10 locations incl. Walnut Creek

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18 - 74

Code: NCT07573176·Phase 3·Recruiting

Apply to this trial

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

for Recurrent T-Cell Non-Hodgkin Lymphoma

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT07225985·Phase 1, Phase 2·Recruiting

Apply to this trial

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

for Hemophilia A

Drug: NXT007

3 locations incl. Orange

Sponsor: Hoffmann-La Roche

Sex: All·Age: 12+

Code: NCT07416604·Phase 3·Recruiting

Apply to this trial

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

for Breast Cancer - Infiltrating Ductal Carcinoma

4 locations incl. Gresham

Sponsor: Legacy Health System

Sex: All·Age: 18+

Code: NCT07506876·Phase 2·Recruiting

Apply to this trial

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

51 locations incl. Tucson

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07195734·Phase 2·Recruiting

Apply to this trial

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

for Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

5 locations incl. St. Petersburg

Sponsor: Grifols Biologicals, LLC

Sex: All·Age: 18+

Code: NCT07582432·Phase 3·Recruiting

Apply to this trial

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

for Obesity

Drug: NNC0487-0111

13 locations incl. Anniston

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07503210·Phase 3·Recruiting

Apply to this trial

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for Obesity

Drug: NNC0487-0111

19 locations incl. Escondido

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07509307·Phase 3·Recruiting

Apply to this trial

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for Relapsing Remitting Multiple Sclerosis

6 locations incl. Atlanta

Sponsor: SetPoint Medical Corporation

Sex: All·Age: 22 - 50

Code: NCT06796504·Recruiting

Apply to this trial

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for Lymphoma, Non-Hodgkin's

Drug: LY4584180

21 locations incl. Scottsdale

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07226843·Phase 1·Recruiting

Apply to this trial

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for Hypoparathyroidism

Drug: Palopegteriparatide

3 locations incl. Reno

Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All·Age: 18+

Code: NCT07081997·Phase 3·Recruiting

Apply to this trial

Nuestro Valor: Increasing Healthier Food Access for Rural Latino Communities Through a Food Retail Intervention

for Hispanic Americans

2 locations incl. Granger

Sponsor: University of Washington

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07490652·Recruiting

Apply to this trial

Autus Valve Continued Access Study (CAS)

for Congenital Heart Disease

10 locations incl. Los Angeles

Sponsor: Autus Valve Technologies, Inc.

Sex: All·Age: 18 Months - 16

Code: NCT07466745·Not Yet Recruiting

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for Macular Degeneration

9 locations incl. Mountain View

Sponsor: EyeBiotech Ltd.

Sex: All·Age: 50+

Code: NCT07496567·Phase 2, Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

25 locations incl. Anniston

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT07430306·Phase 3·Recruiting

Apply to this trial

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for Obesity

Drug: NNC0487-0111

19 locations incl. Phoenix

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07481630·Phase 3·Recruiting

Apply to this trial

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

for Type I Diabetes

5 locations incl. Birmingham

Sponsor: Op-T LLC

Sex: All·Age: 18 - 50

Code: NCT06964087·Phase 2·Recruiting

Apply to this trial

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

for Chronic Inflammatory Demyelinating Polyneuropathy

3 locations incl. Palo Alto

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18 - 75

Code: NCT07304154·Phase 1·Recruiting

Apply to this trial